-Bloomberg
Read Why Carter’s Shares Are Soaring Today
Carter’s Inc (NYSE:CRI) reported fourth-quarter FY21 sales growth of 11.1% year-on-year, to $1.10 billion, beating the analyst consensus estimate of $1.03…
Related Posts
Pfizer Shares Top-Line Results From Phase 2/3 EPIC-PEP Study Of PAXLOVIDTM For Post-Exposure Prophylactic Use; Says Results Of Study Were Not Statistically Significant
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-shares-top-line-results-phase-23-epic-pep-study
Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial
Psychedelics company Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Science Inc. has entered into a research services agreement with Canadian-based biotech Nova Mentis Life Science Corp.